EW
Edwards Lifesciences Corporation · Healthcare · Medical - Devices
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q2 2024
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 163 | -6 | 423.46M | $38.23B | +2 | −9 |
| Q1 2026 | 173 | +2 | 408.99M | $32.75B | +6 | −5 |
| Q4 2025 | 170 | 0 | 441.50M | $37.63B | +2 | −1 |
| Q3 2025 | 24 | -1 | 280.60M | $21.82B | +1 | −3 |
| Q2 2025 | 23 | 0 | 232.09M | $18.15B | n/a | n/a |
| Q1 2025 | 20 | -1 | 112.98M | $8.18B | n/a | −1 |
| Q4 2024 | 21 | +1 | 116.40M | $8.61B | +1 | n/a |
| Q3 2024 | 19 | +1 | 77.58M | $5.12B | +2 | −1 |
| Q2 2024 | 18 | n/a | 60.09M | $5.55B | n/a | n/a |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 16.92M | n/a | $1.56B | 0.3% | n/c | 1 | SEC ↗ ×9 |
| 2 | Geode Capital Management ✦ (pasif) | 13.24M | n/a | $1.22B | 0.1% | n/c | 1 | SEC ↗ ×2 |
| 3 | Norges Bank ✦ (pasif) | 8.54M | n/a | $788.63M | 0.1% | n/c | 1 | SEC ↗ |
| 4 | Fisher Asset Management ✦ | 8.27M | n/a | $764.05M | 0.3% | n/c | 1 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 7.34M | n/a | $677.60M | 0.1% | n/c | 1 | SEC ↗ ×2 |
| 6 | PRIMECAP Management ✦ | 1.81M | n/a | $167.28M | 0.1% | n/c | 1 | SEC ↗ |
| 7 | Adage Capital Partners ✦ | 649.66K | n/a | $60.01M | 0.1% | n/c | 1 | SEC ↗ |
| 8 | Citadel Advisors ✦ | 624.40K | n/a | $57.68M | 0.1% | n/c | 1 | SEC ↗ ×2 |
| 9 | Millennium Management ✦ | 524.21K | n/a | $48.42M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Bridgewater Associates ✦ | 519.81K | n/a | $48.02M | 0.3% | n/c | 1 | SEC ↗ |
| 11 | Point72 Asset Management ✦ | 444.16K | n/a | $41.03M | 0.1% | n/c | 1 | SEC ↗ |
| 12 | Baillie Gifford ✦ | 352.30K | n/a | $32.54M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 13 | AQR Capital Management ✦ | 309.12K | n/a | $28.55M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 14 | Arrowstreet Capital ✦ | 225.02K | n/a | $20.79M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Two Sigma Investments ✦ | 152.01K | n/a | $14.04M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | D. E. Shaw & Co. ✦ | 89.65K | n/a | $8.28M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 17 | Marshall Wace ✦ | 74.67K | n/a | $6.90M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Gotham Asset Management ✦ | 11.86K | n/a | $1.10M | 0.0% | n/c | 1 | SEC ↗ |
"Their weight" = porsi posisi dari nilai ekuitas 13F yang dilaporkan manajer tersebut: ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Tidak ada pembeli terlacak baru kuartal ini. |
Telah keluar
| Tidak ada keluar yang terlacak kuartal ini. |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 4 pemegang, 229.24K saham, $319,498 dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang sekuritas ini yang dilacak: jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Tidak ada pembelian insider di pasar terbuka dalam jendela cakupan kami.
Penjualan di pasar terbuka (S)
Officer · 619 lbr · $53,017
Officer · 619 lbr · $54,169
Officer · 544 lbr · $49,534
Officer · 2.64K lbr · $237,907
Officer · 1.24K lbr · $113,417
Officer · 1.15K lbr · $105,893
Officer · 30.65K lbr · $2.79M
Officer · 619 lbr · $56,967
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi